Triumph Capital Management’s Clover Health Investments CLOV Stock Holding History
Bought
Maintained
Sold
Other funds holding CLOV
Triumph Capital Management's CLOV Position: Q2 2026 in Review
Triumph Capital Management reduced its Clover Health Investments (CLOV) stake by 0.2% in Q2 2026, selling an estimated $27 and leaving 4,000 shares worth $21K. The position accounts for ﹤0.01% of the portfolio, ranked #925.
Triumph Capital Management first reported a position in CLOV in Q4 2024 and has held it in 5 quarters since. The position peaked at $44.8K in Q4 2024. 227 funds tracked by Wall St. Rank hold CLOV as of Q2 2026.
- Triumph Capital Management held 4,000 shares of Clover Health Investments worth $21K as of Q2 2026.
- Triumph Capital Management sold 8 Clover Health Investments shares in Q2 2026, an estimated $27.
- Clover Health Investments made up ﹤0.01% of Triumph Capital Management's portfolio in Q2 2026, its #925 holding.
- Triumph Capital Management first reported a position in Clover Health Investments in Q4 2024 and has held it in 5 quarters since.
- Triumph Capital Management's Clover Health Investments position peaked at $44.8K in Q4 2024.
- 227 funds tracked by Wall St. Rank held Clover Health Investments as of Q2 2026.
Based on Triumph Capital Management's 13F filing for Q2 2026, filed 21 Jul 2026.